Ami Drugs And Speciality Chemicals Private Limited, a active private limited company, was established on 28 January 2003 in Vadodara, Gujarat, India. Engaging in chemical distribution & retail within the trade sector, it holds CIN: U24231GJ2003PTC041913. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.50 M.
It upholds a compliant status. Its leadership includes Kiranben Girishbhai Chovatia (Director), Girishkumar Limbabhai Chovatia (Director), Ameeshi Girishkumar Chovatia (Director). Past directors included Limbabhai Arjanbhai Chovatia, Ameeshi Girishkumar Chovatia, Shivani Rudreshkumar Trivedi. It holds no open charges and ₹1.45 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 201 Tanishq Opp Sbiurmibr Productivity Road, Vadodara, Gujarat, 390020.
U24231GJ2003PTC041913
041913
28 January 2003
₹1.00 Cr
₹1.50 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Ami Drugs And Speciality Chemicals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kiranben Girishbhai Chovatia | Director | 28 Jan 2003 | Current |
| Girishkumar Limbabhai Chovatia | Director | 28 Jan 2003 | Current |
| Ameeshi Girishkumar Chovatia | Director | 12 Jul 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Aug 2015 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
| Pramod Abcsdd | Director | 24 Dec 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ami Drugs And Speciality Chemicals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 93.92% decrease. The company also saw a substantial fall in profitability, with a 98.01% decrease in profit. The company's net worth moved up by a moderate rise of 1.62%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Ami Drugs And Speciality Chemicals had a promoter holding of 47.13% and a public holding of 52.87%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹14,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2007 | Uti Bank Ltd | ₹8.00 M | Satisfied |
| 28 Apr 2005 | State Bank Of Saurashtra | ₹6.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Ami Drugs And Speciality Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ami Drugs And Speciality Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ami Drugs And Speciality Chemicals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Ami Drugs And Speciality Chemicals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Ami Drugs And Speciality Chemicals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.
A charge registered on 30 Mar 2007 via Charge ID 10048079 with Uti Bank Ltd was fully satisfied on 18 Nov 2017. was recorded as a recent event.
Ameeshi Girishkumar Chovatia was appointed as a Director was appointed as a Director on 12 Jul 2017 & has been associated with this company since 8 years 4 months . was recorded as a recent event.
The activity A charge registered on 28 Apr 2005 via Charge ID 90102461 with State Bank Of Saurashtra was fully satisfied on 27 Jul 2007. was completed.
A charge with Uti Bank Ltd amounted to Rs. 0.80 Cr with Charge ID 10048079 was registered on 30 Mar 2007. was recorded as a recent event.
The CIN of Ami Drugs And Speciality Chemicals Private Limited is U24231GJ2003PTC041913.
Ami Drugs And Speciality Chemicals Private Limited is headquartered at 201 Tanishq Opp Sbiurmibr Productivity Road, Vadodara, Gujarat, 390020.
Ami Drugs And Speciality Chemicals Private Limited was incorporated on 28 January 2003.
The current directors of Ami Drugs And Speciality Chemicals Private Limited are
The primary industry of Ami Drugs And Speciality Chemicals Private Limited is Trade.
Ami Drugs And Speciality Chemicals Private Limited is unlisted.
The authorized capital of Ami Drugs And Speciality Chemicals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.50 M.
The compliance status of Ami Drugs And Speciality Chemicals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX